Home The Word Brain My Amedeo FAQ Privacy About   


C49

In our changing world, speaking just English isn't enough. Open new doors with skills in another world language.

Start with 7 words a day.

Next week: +49.


  Cervical Cancer

  Free Subscription


Articles published in Int J Gynaecol Obstet

Retrieve available abstracts of 59 articles:
HTML format



Single Articles


    May 2025
  1. LI DM, Liu QY, Xue SL, Zeng X, et al
    Accuracy analysis of cervical cancer screening using urine and vaginal self-sampling versus clinician-collected samples: A systematic review and meta-analysis.
    Int J Gynaecol Obstet. 2025 May 13. doi: 10.1002/ijgo.70207.
    PubMed     Abstract available


  2. ROMANISHIN A, Efimenko B, Katserov D, Agapov M, et al
    Comprehensive cross-sectional study of CIN prevalence, HPV genotyping, genetic alterations, and microbiota as molecular biomarkers for early cervical cancer detection: A pilot clinical study among women in Russia.
    Int J Gynaecol Obstet. 2025 May 5. doi: 10.1002/ijgo.70090.
    PubMed     Abstract available


    April 2025
  3. SHANG X, Kong L, You Y, Wu H, et al
    Cytologic DNA methylation for managing minimally abnormal cervical cancer screening results.
    Int J Gynaecol Obstet. 2025 Apr 16. doi: 10.1002/ijgo.70167.
    PubMed     Abstract available


  4. FUSEINI NM, El Joueidi S, Montgomery T, Lemrabott E, et al
    Cervical precancer screening and treatment in Nouakchott, Mauritania: Pilot program to inform development of Mauritania's national cervical cancer prevention program.
    Int J Gynaecol Obstet. 2025 Apr 11. doi: 10.1002/ijgo.70145.
    PubMed    


  5. JAREEMIT N, Theerarojanapong L, Laokulrath N, Achariyapota V, et al
    Yield of endocervical curettage in detecting cervical intraepithelial neoplasia grade 2 or higher during colposcopy: A prospective, cross-sectional study.
    Int J Gynaecol Obstet. 2025;169:105-111.
    PubMed     Abstract available


  6. GUNGORDUK K, Unver HC, Uyar BS, Ergu BN, et al
    Efficacy of chitosan powder in reducing vaginal bleeding following a loop electrosurgical excision procedure: A randomized control trial.
    Int J Gynaecol Obstet. 2025;169:240-246.
    PubMed     Abstract available


  7. VAN DE LAAR RLO, Jordans CCE, Salmaan A, Hofhuis W, et al
    High acceptability of point-of-care HIV testing at the colposcopy outpatient clinic in hospitals in the Netherlands.
    Int J Gynaecol Obstet. 2025;169:155-162.
    PubMed     Abstract available


    March 2025
  8. MIYOSHI A, Isohashi F, Fujii M, Iwamiya T, et al
    The association between additional radiotherapy after systemic chemotherapy and the prognosis of stage FIGO 2018 IVB cervical cancer.
    Int J Gynaecol Obstet. 2025 Mar 22. doi: 10.1002/ijgo.70077.
    PubMed     Abstract available


    February 2025
  9. CUBAKA NTAMUSHIGO J, Motshedisi Sebitloane H
    Review of triage strategies for atypical squamous cells of undetermined significance among young women.
    Int J Gynaecol Obstet. 2025;168:428-435.
    PubMed     Abstract available


  10. YIM GW, Lee J, Yang K, Lee CH, et al
    A pilot study of upcycled smartphone-based colposcopy for visual inspection of cervix performed by community healthcare workers in rural Vietnam.
    Int J Gynaecol Obstet. 2025;168:518-524.
    PubMed     Abstract available


    December 2024
  11. BIZZARRI N, Kyrgiou M, De Vincenzo R, Zapardiel I, et al
    Prophylactic HPV vaccination in HPV-related gynecologic cancers: European Society of Gynecological Oncology (ESGO) prevention committee opinion.
    Int J Gynaecol Obstet. 2024 Dec 30. doi: 10.1002/ijgo.16120.
    PubMed     Abstract available


  12. TAKAMOTO N, Aso S, Ishida R, Konishi T, et al
    Cost-effectiveness analysis of 9-valent human papillomavirus vaccine combined with screening for cervical cancer in Japan.
    Int J Gynaecol Obstet. 2024 Dec 28. doi: 10.1002/ijgo.16125.
    PubMed     Abstract available


  13. MUNGO C, Omoto J, Ogollah C, Owaya A, et al
    Safety and adherence to self-administered intravaginal 5-fluorouracil cream following cervical intraepithelial neoplasia (CIN) 2/3 treatment among HIV-positive women in Kenya: A phase 1 clinical trial.
    Int J Gynaecol Obstet. 2024 Dec 26. doi: 10.1002/ijgo.16093.
    PubMed     Abstract available


  14. LYU YH, Liu HX, Han X, Yuan P, et al
    Clinicopathologic characteristics and prognostic factors of patients with surgically treated high-grade neuroendocrine carcinoma of the cervix: A multicenter retrospective study.
    Int J Gynaecol Obstet. 2024;167:1055-1065.
    PubMed     Abstract available


    November 2024
  15. LIU Y, Yang S, Ma Y, Gong Y, et al
    HPV E6/E7 mRNA screening alone can be used as a screening method for cervical cancer in premenopausal women in China: A retrospective study.
    Int J Gynaecol Obstet. 2024 Nov 25. doi: 10.1002/ijgo.16043.
    PubMed     Abstract available


  16. XU P, Mageswaran UM, Nisaa AA, Balasubramaniam SD, et al
    Roles of probiotics against HPV through the gut-vaginal axis.
    Int J Gynaecol Obstet. 2024 Nov 9. doi: 10.1002/ijgo.16005.
    PubMed     Abstract available


  17. WU T, Sun R, Sun J, Tao X, et al
    Circulating tumor HPV DNA as a specific biomarker for cervical cancer.
    Int J Gynaecol Obstet. 2024 Nov 8. doi: 10.1002/ijgo.16011.
    PubMed     Abstract available


    October 2024
  18. SADAT R, Sacinti KG, Topcu EG, Saeed S, et al
    Overcoming barriers to cervical cancer prevention in Afghanistan: The imperative for an HPV vaccination and screening program.
    Int J Gynaecol Obstet. 2024 Oct 16. doi: 10.1002/ijgo.15956.
    PubMed    


    September 2024
  19. DEGENNARO V JR, Henderson RR, Petterson C, Wilson C, et al
    Working towards health: A model of cervical cancer screening and treatment for factory employees in Haiti.
    Int J Gynaecol Obstet. 2024 Sep 27. doi: 10.1002/ijgo.15940.
    PubMed     Abstract available


  20. CAO Y, Xiao X, Liang D, Lu Y, et al
    HPV 16/18 E7 oncoprotein detection as a promising triage strategy for HPV 16/18-positive patients: A prospective multicenter study with a 2-year follow up.
    Int J Gynaecol Obstet. 2024 Sep 8. doi: 10.1002/ijgo.15897.
    PubMed     Abstract available


    August 2024
  21. YURTCU E, Ozvural S, Keyif B
    Analyzing the performance of ChatGPT in answering inquiries about cervical cancer.
    Int J Gynaecol Obstet. 2024 Aug 16. doi: 10.1002/ijgo.15861.
    PubMed     Abstract available


    June 2024
  22. WANG R, Ma L, Xiao Y, Jiang H, et al
    A case of postoperative non-invasive mucosal implantation of early-stage cervical adenocarcinoma to the clitoris.
    Int J Gynaecol Obstet. 2024;165:1295-1297.
    PubMed    


  23. DESCAMPS P, Dixon S, Bosch Jose FX, Kyrgiou M, et al
    Turning the tide-Recommendations to increase cervical cancer screening among women who are underscreened.
    Int J Gynaecol Obstet. 2024;166 Suppl 1:3-21.
    PubMed    


    May 2024
  24. YANG ST, Liu HH, Liu CH, Wang LW, et al
    Bevacizumab is associated with a higher gastrointestinal/genitourinary fistula or perforation risk in cervical cancer patients undergoing pelvic radiotherapy.
    Int J Gynaecol Obstet. 2024 May 15. doi: 10.1002/ijgo.15609.
    PubMed     Abstract available


  25. ALIABADI AR, Wilailak S, McNally O, Berek JS, et al
    Contraceptive strategies for reducing the risk of reproductive cancers.
    Int J Gynaecol Obstet. 2024 May 9. doi: 10.1002/ijgo.15567.
    PubMed     Abstract available


  26. MWANDACHA N, Dau H, AboMoslim M, Naguti P, et al
    Investigating the healthcare-seeking behaviors of mobile phone users to improve cervical cancer screening in rural Uganda.
    Int J Gynaecol Obstet. 2024 May 4. doi: 10.1002/ijgo.15577.
    PubMed     Abstract available


    April 2024
  27. ALFAREH M, Obeid D, Alhoshan H, Basri R, et al
    Low uptake of Pap test as a cervical cancer screen among Saudi women: Findings from a national survey.
    Int J Gynaecol Obstet. 2024 Apr 19. doi: 10.1002/ijgo.15532.
    PubMed     Abstract available


  28. PATEL A, Suneja A, Malik R, Gupta B, et al
    Chromocolposcopy with fluorescein sodium for detection of premalignant and malignant lesions of the cervix: A cross-sectional study.
    Int J Gynaecol Obstet. 2024;165:169-175.
    PubMed     Abstract available


    March 2024
  29. HERNANDEZ JA, Rodriguez J, Rendon G, Trujillo LM, et al
    Pelvic lymph node involvement and risk of recurrence in HPV-associated endocervical adenocarcinoma stage IA2-IB1 according to Silva's system in two Colombian cancer centers.
    Int J Gynaecol Obstet. 2024 Mar 28. doi: 10.1002/ijgo.15482.
    PubMed     Abstract available


  30. XU JY, Hu M, Wu SG, Zhou J, et al
    Local treatment strategies in Stage IVB cervical squamous cell carcinoma and adenocarcinoma.
    Int J Gynaecol Obstet. 2024;164:1053-1063.
    PubMed     Abstract available


  31. STRATULAT V, Melamed N, Barrett J, Ladhani NNN, et al
    Cervical assessment certification and its impact on performance quality in the context of universal cervical screening.
    Int J Gynaecol Obstet. 2024;164:951-958.
    PubMed     Abstract available


    February 2024
  32. MARINO-NOYA A, Magallanes-Pelaez N, Puga-Gonzalez N, Conde-Ferreiros M, et al
    Cervical carcinosarcoma, report of some cases and a literature review.
    Int J Gynaecol Obstet. 2024;164:795-796.
    PubMed    


  33. JIA L, Wang L, Zheng J, Lu J, et al
    Ureter metastasis from a primary cervical malignancy 3 years after initial treatment.
    Int J Gynaecol Obstet. 2024;164:793-794.
    PubMed    


    January 2024
  34. LIANG C, Su G, Sun L, Zhao H, et al
    Comparison of the clinical outcomes of patients with stage IA-IIA2 cervical adenocarcinoma and squamous cell carcinoma after radical hysterectomy: A propensity score-matched real-world analysis.
    Int J Gynaecol Obstet. 2024 Jan 29. doi: 10.1002/ijgo.15388.
    PubMed     Abstract available


  35. SABEENA S, Ravishankar N, Kalpana MM
    Implementation strategies of cervical cancer screening in South Asia: A systematic review.
    Int J Gynaecol Obstet. 2024 Jan 24. doi: 10.1002/ijgo.15366.
    PubMed     Abstract available


  36. VAN DE SANDE AJM, Kengsakul M, Koeneman MM, Jozwiak M, et al
    The efficacy of topical imiquimod in high-grade cervical intraepithelial neoplasia: A systematic review and meta-analysis.
    Int J Gynaecol Obstet. 2024;164:66-74.
    PubMed     Abstract available


    December 2023
  37. TANG X, Zhang X, Ding Y, Zhang Y, et al
    A long-term retrospective analysis of management of cervical cancer during pregnancy.
    Int J Gynaecol Obstet. 2023 Dec 27. doi: 10.1002/ijgo.15314.
    PubMed     Abstract available


  38. DESRAVINES N, Hsu CH, Mohnot S, Sahasrabuddhe V, et al
    Feasibility of 5-fluorouracil and imiquimod for the topical treatment of cervical intraepithelial neoplasias (CIN) 2/3.
    Int J Gynaecol Obstet. 2023;163:862-867.
    PubMed     Abstract available


    November 2023
  39. ZHANG Y, Wang C, Zhao Z, Cheng L, et al
    Survival outcomes of 2018 FIGO stage IIIC versus stages IIIA and IIIB in cervical cancer: A systematic review with meta-analysis.
    Int J Gynaecol Obstet. 2023 Nov 11. doi: 10.1002/ijgo.15218.
    PubMed     Abstract available


  40. LUCKETT R, Ramogola-Masire D, Gompers A, Moraka N, et al
    Triage of HPV positivity in a high HIV prevalence setting: A prospective cohort study comparing visual triage methods and HPV genotype restriction in Botswana.
    Int J Gynaecol Obstet. 2023 Nov 10. doi: 10.1002/ijgo.15225.
    PubMed     Abstract available


  41. HILL SK, Bempong-Ahun N, Okolo ID, Lalla AT, et al
    Improving access to safe, quality surgical care for gynecologic cancers through capacity-building interventions in low- and middle-income countries: A scoping review.
    Int J Gynaecol Obstet. 2023 Nov 5. doi: 10.1002/ijgo.15156.
    PubMed     Abstract available


  42. RAMESAN CK, Calvin JD, Thomas A, Fletcher J, et al
    Diagnostic study of human papillomavirus DNA detection in cervical and vaginal samples using the filter paper card.
    Int J Gynaecol Obstet. 2023;163:660-666.
    PubMed     Abstract available


    October 2023
  43. VARGAS-CARDONA HD, Rodriguez-Lopez M, Arrivillaga M, Vergara-Sanchez C, et al
    Artificial intelligence for cervical cancer screening: Scoping review, 2009-2022.
    Int J Gynaecol Obstet. 2023 Oct 9. doi: 10.1002/ijgo.15179.
    PubMed     Abstract available


  44. REIJNTJES B, Eising M, Kleppe M, Geuken E, et al
    The clinical relevance of excisional margins after large loop excision of the transformation zone for the persistence of cervical dysplasia.
    Int J Gynaecol Obstet. 2023;163:140-147.
    PubMed     Abstract available


  45. HAMAR B, Teutsch B, Hoffmann E, Hegyi P, et al
    Trichomonas vaginalis infection is associated with increased risk of cervical carcinogenesis: A systematic review and meta-analysis of 470 000 patients.
    Int J Gynaecol Obstet. 2023;163:31-43.
    PubMed     Abstract available


    September 2023
  46. LIU Y, He J, Liu P, Chen C, et al
    Postoperative management of FIGO 2018 stage IIA1 cervical squamous cell carcinoma with only one intermediate-risk factor: Is radiotherapy needed?
    Int J Gynaecol Obstet. 2023;162:1098-1105.
    PubMed     Abstract available


  47. ZHOU Y, Wang C, Li W, Lu W, et al
    Fluorescence colposcope with TMTP1-PEG4-ICG is comparable to the conventional colposcope in identifying cervical precancerous lesions: A randomized controlled trial.
    Int J Gynaecol Obstet. 2023;162:969-976.
    PubMed     Abstract available


    July 2023
  48. AMARAL E, Cain JM, Hearing F, Lumsden MA, et al
    FIGO guidance for sustainable implementation of vaccination programs for women: Pregnancy and HPV.
    Int J Gynaecol Obstet. 2023;162 Suppl 1:3-23.
    PubMed    


    June 2023
  49. BONI SP, Horo A, Didi-Kouko-Coulibaly J, Tanon A, et al
    Impact of HIV infection on access to cancer care and survival among women with invasive cervical cancer in Cote d'Ivoire: A prospective cohort study.
    Int J Gynaecol Obstet. 2023 Jun 22. doi: 10.1002/ijgo.14925.
    PubMed     Abstract available


  50. KASUGA Y, Hasegawa K, Hamuro A, Fukuma Y, et al
    Pregnancy outcomes following radical trachelectomy for early-stage cervical cancer: A retrospective observational study in the Kanto area, Japan.
    Int J Gynaecol Obstet. 2023 Jun 21. doi: 10.1002/ijgo.14935.
    PubMed     Abstract available


  51. TOGAMI S, Tokudome A, Fukuda M, Mizuno M, et al
    Validation of single-photon emission computed tomography with computed tomography and lymphoscintigraphy for sentinel lymph node identification in cervical cancer.
    Int J Gynaecol Obstet. 2023 Jun 18. doi: 10.1002/ijgo.14917.
    PubMed     Abstract available


    May 2023
  52. DE LA CRUZ-RAMIREZ YM, Olaza-Maguina AF
    Barriers to HPV vaccine uptake in adolescents of the indigenous Andean community of Peru.
    Int J Gynaecol Obstet. 2023 May 5. doi: 10.1002/ijgo.14844.
    PubMed    


    April 2023
  53. GIANNELLA L, Delli Carpini G, Di Giuseppe J, Gardella B, et al
    Should attention be paid to the cone depth in the fully visible transformation zone? Retrospective analysis of 517 patients with cervical intraepithelial neoplasia grade 3.
    Int J Gynaecol Obstet. 2023;161:137-143.
    PubMed     Abstract available


  54. TEHRANIAN A, Ghahghaei-Nezamabadi A, Seifollahi A, Mansouri P, et al
    Concurrent anorectal and cervical cytology in women with positive and negative cervical smear test results: A cross-sectional study.
    Int J Gynaecol Obstet. 2023;161:100-105.
    PubMed     Abstract available


    February 2023
  55. MCCLYMONT E, Money D
    The shift to one-dose HPV vaccination: Where does this leave women living with HIV?
    Int J Gynaecol Obstet. 2023 Feb 20. doi: 10.1002/ijgo.14713.
    PubMed    


    December 2022
  56. MATSUO K, Violette CJ, Mandelbaum RS, Shoupe D, et al
    Utilizations and characteristics of ovarian conservation at hysterectomy for cervical carcinoma in-situ.
    Int J Gynaecol Obstet. 2022 Dec 1. doi: 10.1002/ijgo.14604.
    PubMed     Abstract available


    November 2022
  57. BAO H, Zhao Y, Zhang X, Bi H, et al
    HPV-negative high-grade cervical precancerous lesions or invasive cancer in China: A post hoc analysis of a multicentric clinical study.
    Int J Gynaecol Obstet. 2022 Nov 29. doi: 10.1002/ijgo.14598.
    PubMed     Abstract available


    October 2022
  58. JOHN JH, Halder A, Purwar S, Pushpalatha K, et al
    Study to determine efficacy of Urinary HPV 16 &18 detection in predicting premalignant and malignant lesions of Uterine Cervix.
    Int J Gynaecol Obstet. 2022 Oct 2. doi: 10.1002/ijgo.14486.
    PubMed     Abstract available


    September 2022
  59. VORA KS, Saiyed S, Joshi R, Natesan S, et al
    Prevalence of High Risk HPV amongst marginalized urban women in India and its implications on vaccination: A cross sectional study.
    Int J Gynaecol Obstet. 2022 Sep 1. doi: 10.1002/ijgo.14428.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.